Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
about
Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisTriazole Resistance in Aspergillus Species: An Emerging Problem.Fungal PDR transporters: Phylogeny, topology, motifs and function.Milbemycin A4 oxime as a probe of azole transport in Candida glabrataThe monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei.Upregulation of the ERG11 gene in Candida krusei by azolesEfflux-mediated antifungal drug resistance.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Role of Ectopic Gene Conversion in the Evolution of a Candida krusei Pleiotropic Drug Resistance Transporter Family.Current status of antifungal resistance and its impact on clinical practice.Multiple mechanisms contribute to the development of clinically significant azole resistance in Aspergillus fumigatus.Whole Genome Sequence of the Heterozygous Clinical Isolate Candida krusei 81-B-5.Vulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Efflux as a mechanism of antimicrobial drug resistance in clinical relevant microorganisms: the role of efflux inhibitors.Fluconazole resistance in Candida species: a current perspective.Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.Identification and functional characterization of Penicillium marneffei pleiotropic drug resistance transporters ABC1 and ABC2.Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida speciesAntifungal resistance and new strategies to control fungal infections.Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP.In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.The UPC2 promoter in Candida albicans contains two cis-acting elements that bind directly to Upc2p, resulting in transcriptional autoregulation.Novel antifungal activity of purpurin against Candida species in vitro.Antifungals discovery: an insight into new strategies to combat antifungal resistance.ERG11 mutations and upregulation in clinical itraconazole-resistant isolates of Candida krusei.Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.Population genomics shows no distinction between pathogenic Candida krusei and environmental Pichia kudriavzevii: One species, four names
P2860
Q26863344-D5744703-AB0E-4F79-96F3-1326259F86E4Q28818603-ACAC82C1-D109-455B-A8BC-7065F2564CBEQ30235566-F7EDA628-A3BE-4AC9-8AF1-B05DAD00A519Q33624643-D7403C9C-E0B3-4C5B-ACA4-8B851E62CF51Q34021031-2973CE37-C794-4B92-BBA6-FEA596E49C3DQ34112865-2BCFBCEF-F38F-40CB-8CC0-C2CA4D1D7571Q35756098-99223FCC-E81C-40BB-BDC0-3007A2C768DFQ35832184-D464E35F-0439-402A-A937-F674A8661318Q37156645-285D3304-4C38-4F5C-A387-CD79482BFCCEQ37580801-770F1537-86B6-4129-9115-9163DF1869A1Q37735455-3918F67E-C2BF-45DD-8614-EC1C0B4827D5Q38205859-99C21F5E-657C-4121-9DCB-DAEC92A65CC8Q38365013-019FF946-5889-4E96-90A9-D69A50F2856DQ38684199-662DA25C-E2B6-483A-8835-DFBAF0F3D6FDQ38696236-7128D3AA-41C5-4567-8F52-58B59598CA79Q39021961-8FB8C83F-64CA-4FE2-8867-5644487FBD1DQ39092120-E0EDDE2F-964F-41F7-9698-56B13E320AFEQ39207667-63C26637-24F3-4667-9CDE-0FE93DD997DFQ39335647-F5892537-20D4-4D3F-A943-35C33A5E4DB0Q39388869-B86EF2C3-C4A1-4C4E-B318-22D23D228233Q39751373-2CC96B9A-0148-4E08-B1D5-96C269D4DA12Q42003526-E1E8C2F8-1BB2-46D8-8C75-FBD5CE413435Q42109755-AD39870D-6267-42DD-8320-ED140D1660B1Q42428468-1F186D7C-A5EC-4A77-8D14-B86EA4479C0AQ43099651-67E0CF0E-445D-45BA-AF0C-13B383C50109Q50122600-A1A178EC-3462-4CF6-A1DB-59585BF809E2Q51512831-8A68F1F5-886D-4B92-B769-AAD363065161Q53622505-03EB8F1D-4274-4955-8A77-B4E307BAFA40Q55931964-9E78F75E-F5FC-4094-BD18-012CB5BD4820
P2860
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Abc1p is a multidrug efflux tr ...... resistance in Candida krusei.
@en
Abc1p is a multidrug efflux tr ...... resistance in Candida krusei.
@nl
type
label
Abc1p is a multidrug efflux tr ...... resistance in Candida krusei.
@en
Abc1p is a multidrug efflux tr ...... resistance in Candida krusei.
@nl
prefLabel
Abc1p is a multidrug efflux tr ...... resistance in Candida krusei.
@en
Abc1p is a multidrug efflux tr ...... resistance in Candida krusei.
@nl
P2093
P2860
P50
P356
P1476
Abc1p is a multidrug efflux tr ...... e resistance in Candida krusei
@en
P2093
Amrita Ranchod
Kenjirou Nakamura
Kyoko Niimi
Masakazu Niimi
P2860
P304
P356
10.1128/AAC.01095-08
P407
P577
2008-11-17T00:00:00Z